Armada Acquisition Corp. III (AACI) vs Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)

A side-by-side comparison of Armada Acquisition Corp. III and Drugs Made In America Acquisition Corp. Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AACI vs DMAA

growth of $100 · dividends reinvested · last 1y
AACI +2.3% (+2.3%/yr)DMAA +3.6% (+3.6%/yr)DMAA compounded faster over this window
100101102103Start $100$102$104
AACI DMAA

AACI vs DMAA: by the numbers

  • •DMAA is the larger company ($265M vs $258M market cap).
  • •DMAA trades at the lower trailing earnings multiple (55.53 vs 126.09 P/E), one valuation lens rather than an overall verdict.

Metrics side by side

Valuation

MetricAACIDMAA
P/E ratio126.0955.53
P/B ratio1.061.92

Profitability

MetricAACIDMAA
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE0.96%4.42%
ROIC-0.30%-1.82%

Frequently asked

Which has the lower trailing P/E, AACI or DMAA?
DMAA has the lower trailing P/E: AACI trades at 126.09 and DMAA at 55.53. P/E is one valuation measure and does not by itself establish which business is cheaper.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.